SCHEMBL7029322

SCHEMBL7029322

Cc1ccc(CCc2cc(C)ccc2S(=O)(=O)O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.40
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
GPR84 Q9NQS5 1/20 0.39
POLB P06746 3/20 0.38
RECQL P46063 2/20 0.38
ESR2 Q92731 1/20 0.38
IGF1R P08069 1/20 0.38
ALOX15 P16050 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2A6 P11509 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
GAA P10253 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
CASP6 P55212 1/20 0.37
ELAVL1 Q15717 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1180196 0.91 GAA (0.41) ALDH1A1KMT2AMEN1POLBRECQL
SCHEMBL30823619 0.91 GAA (0.41) ALDH1A1KMT2AMEN1POLBRECQL
SCHEMBL1684413 0.91 PTGES2 (0.45) ALDH1A1KMT2AMEN1POLBRECQL
SCHEMBL21465414 0.91 PTGES2 (0.45) ALDH1A1KMT2AMEN1POLBCYP1A2
SCHEMBL5189165 0.90 TDP1 (0.45) ALDH1A1KMT2AMEN1GAAKDM4E
SCHEMBL7028563 0.90 IGF1R (0.42) DAOALDH1A1KMT2AMEN1POLB
SCHEMBL18917599 0.89 IGF1R (0.40) ALDH1A1KMT2AMEN1POLBRECQL
SCHEMBL10372347 0.88 CALM1 (0.47) ALDH1A1KMT2AMEN1MAPTL3MBTL1
SCHEMBL2622514 0.87 DAO (0.40) DAOALDH1A1KMT2AMEN1GPR84
SCHEMBL7034332 0.86 CTDSP1 (0.44) ALDH1A1KMT2AMEN1GPR84POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042355-B1 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS SCHERING AG (DE) 2003-02-12 EP disclosed
EP-1054676-A1 COMBINATION PREPARATION OF ESTROGEN AND ANTI-ESTROGEN SCHERING AKTIENGESELLSCHAFT (DE) 2000-11-29 EP disclosed
EP-1042355-A1 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS Schering Aktiengesellschaft (DE) 2000-10-11 EP disclosed
WO-1999042109-A1 COMBINATION PREPARATION OF ESTROGEN AND ANTI-ESTROGEN SCHERING AKTIENGESELLSCHAFT (DE) 1999-08-26 WO disclosed
WO-1999033855-A1 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 1999-07-08 WO disclosed